| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC1548 |
| Trial ID | NCT02546739 |
| Disease | Non-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Immunotherapy With CD19 CAR T-cells for B-Cell Lymphoma, ALL and CLL |
| Year | 2015 |
| Country | China |
| Company sponsor | Beijing Doing Biomedical Co., Ltd. |
| Other ID(s) | Doing-002 |
| Cohort 1 | |||||||||
|
|||||||||